Previously, Dr. Burd was Founder & CEO of Oculir, developing a non-invasive glucose testing technology. Prior to Oculir, Dr. Burd was a General Partner of Windamere Venture Partners and Chairman & CEO of MiraMedica. Dr. Burd was the Founder, President, CEO and Chairman of LXN Corporation, and held executive positions at QUIDEL Corporation.